26-1201 Updates to Prior Authorization Requirements
Health Net updated its prior authorization lists for California. Preferred and non-preferred status for the denosumab (Prolia, Xgeva and biosimilars) and ustekinumab biosimilars changed effective immediately, and several procedures and equipment codes stopped needing prior authorization for Medicare members effective November 1, 2026 (already in effect). New prior authorization requirements for wound care, scalp cooling and some outpatient drugs start January 1, 2027, and the notice says prior authorization changes do not confirm benefit coverage.